Thousand Oaks – – October 29, 2026 -- Amgen (NASDAQ:AMGN) will report its third quarter 2026 financial results on Tuesday, November 3, 2026, after the close of U.S. financial markets.

Amgen schedules investor call for 4:30 p.m. ET with CEO Bradway

The earnings release will be followed by a conference call with the investment community at 4:30 p.m. ET. Robert A. Bradway, chairman and chief executive officer, will participate alongside other members of Amgen's senior management team.